Skip to content

AstraZeneca Foundation

Scientific Award AstraZeneca Foundation in Cancer as a Systemic Disease: Insights on Organ Crosstalk

Last verified:

Is this grant right for you? Check your personalised match score. 30s, no email. See my matches →

The AstraZeneca Foundation Scientific Award funds research on cancer as a systemic disease, with emphasis on organ crosstalk mechanisms and their role in tumour progression and treatment response. The call welcomes researchers investigating how interactions between tumour and non-tumour tissues shape cancer biology and therapeutic outcomes.

Details

Funder AstraZeneca Foundation
Consortium No

Who Should Apply

  • Cancer researchers investigating tumour microenvironment and organ crosstalk
  • Researchers with expertise in systemic cancer biology
  • Translational or fundamental researchers bridging molecular and whole-organism perspectives
  • Applicants working in academic or research institutions

Key Dates

  • Applications first listed 12 April 2026; verify current deadline on AstraZeneca Foundation website

Tips for Applicants

  • Ground your proposal in specific organ systems and measurable crosstalk mechanisms, vague systemic claims score poorly.
  • Emphasise translational relevance: how understanding organ crosstalk could improve drug response prediction or identify new therapeutic targets.
  • If your work bridges preclinical and clinical, highlight the patient-centred insight; AstraZeneca Foundation values clinically grounded hypotheses.

Frequently Asked Questions

What is the focus of the AstraZeneca Foundation cancer award?

The award funds research on cancer as a systemic disease, with particular emphasis on understanding organ crosstalk, how interactions between tumour and non-tumour tissues influence disease progression and treatment response.

Who should apply for the AstraZeneca Foundation Scientific Award?

Cancer researchers working on systemic disease mechanisms, tumour microenvironment, or organ interactions at academic or research institutions.

Is a consortium required for the AstraZeneca Foundation cancer award?

No, the award does not require a consortium; single-investigator and small team submissions are eligible.

cancer-biologysystemic-diseaseorgan-crosstalktumor-microenvironmenttranslational-researchastrazeneca-foundation

Summary generated by AI based on published grant information. Always verify details on the funder's website.

More from AstraZeneca Foundation

Browse all open grants →

Browse Related

Could Scientific Award AstraZeneca Foundation in Cancer as a Systemic Disease: Insights on Organ Crosstalk be right for you?

See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.

See my matches free →